Sof foyda bo'yicha sotuv rentabelligi: Artiva (ARTV)

Artiva Biotherapeutics, Inc. (ARTV) tovar belgisi

Artiva Biotherapeutics, Inc. (ARTV) yopiq bioreaktorlarda NK hujayralarini yetishtirishni avtomatlashtirib, inson omili tufayli yuzaga keladigan xatolarni bartaraf etadi. Bazaviy sof savdo marjasi ushbu jarayonlarning samaradorligini ko'rsatadi va uning joriy parametri 0.00 hisoblanadi. Kompaniya individual sintez bosqichini chetlab o'tib, tayyor anti-tumor dori vositalarini ishlab chiqadi. Genetika sohasidagi yuqori nufuz va global hamkorlarning qo'llab-quvvatlashi brendga investorlarning barqaror ishonchini kafolatlaydi.

Artiva Biotherapeutics Inc. (ARTV) - Sotuvning sof marjinal rentabelligi 20.07.2024dan 20.11.2026gacha

artivabio.com (ARTV) moliyaviy va bozor koʻrsatkichlari kesimi

- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
- pul mablag'lari va pul oqimlari ma'lumotlari:
Kompaniyaning barcha koʻrsatkichlari tahlili:Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. yetakchi tovari

Ushbu ko'rsatkich sof foydaning umumiy daromadga nisbati sifatida hisoblanadi va "qog'ozdagi" o'sish ta'sirini istisno qilgan holda, savdoni haqiqiy daromadga aylantirish samaradorligini aniqlaydi. Artiva Biotherapeutics, Inc. (ARTV) uchun yuqori R&D xarajatlari va FDA ning qat'iy nazorati ushbu parametrni kritik darajaga olib chiqadi. Daromad marjasini tahlil qilish kompaniyaning NK-hujayralar terapiyasi sohasidagi kapitalga intensiv to'siqlarni yengib o'tish qobiliyatini baholash imkonini beradi.

Raqobatdosh kompaniyalar tahlili

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|Sof foyda normasi DCTH (Delcath Corp)|YMAB: Sotuvning sof marjinal rentabelligi|AURA - Kompaniya sotuv marjasi|CADL (Candel Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi ARAY (Accuray)|Sof foyda bo'yicha sotuv rentabelligi SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Sof marja|Sof marja Citius Oncology, Inc. CTOR|HURA - Sof foyda bo'yicha sotuv rentabelligi|protaratx.com - Sotuvning sof marjinal rentabelligi|FATE - Sotuvning sof marjinal rentabelligi|WHWK: Sotuvning sof marjinal rentabelligi|TScan Therapeutics (TCRX) - Sotuvning sof marjinal rentabelligi|Sof marja Champions Oncology|Sof marja XBIT|Sotuvning sof marjinal rentabelligi CVM|Sof foyda bo'yicha sotuv rentabelligi OS Therapies Inc. OSTX|Sof marja Radiopharm Theranostics Limited RADX|Sotuvning sof marjinal rentabelligi Adlai Nortye Ltd. ANL|Veru Inc - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi Tempest Therapeutics TPST|XLO: Sotuvning sof marjinal rentabelligi|Enochian BioSciences (RENB) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MURA|Kairos Pharma Ltd - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi OKUR|CytoMed Therapeutics Limited (GDTC) - Sof foyda bo'yicha marjinallik|Sotuvning sof marjinal rentabelligi CRIS (Curis, Inc.)|APLM: Sotuvning sof rentabelligi|Tharimmune Corporation - Sotuvning sof marjinal rentabelligi|ADVB: Sof marja|GNPX: Sotuvning sof marjinal rentabelligi|CLDI (Calidi Biotherapeutics Inc.) - Sof marja|Sof marja Sunshine Biopharma, Inc.|Sotuvning sof marjinal rentabelligi xeneticbio.com|Sof marja Salarius (SLRX)|Sof foyda bo'yicha sotuv rentabelligi Purple Biotech PPBT|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)